The Pharmaceutical Research and Manufacturers of America wants the Trump administration to reverse compulsory licensing in Malaysia and end "discriminatory" market access practices.
Deregulation of medical practitioners’ consultation fees, jail for not issuing prescriptions upon request, drug price controls, promotion of contract government doctors, vaping regulations, mySalam, and health financing reform.